The next new wave of personalized medicine will be customizable, patient-specific drugs. 3D bioprinting can tailor the geometry of a drug tablet to impact drug loading, release rate, and taste.
In the long run, our bioprinting technology will inspire solutions to address the shortage of organs for transplantation. Printing fully functional tissues and organs will become reality and enter clinical practice powered by advancements in biomaterials, bioprinting techniques and cell technology. Brinter is leading bioprinting companies in the quest for unlimited transplants.